• Info
  • Insider Ownership

Insider Trading & Ownership of John A. Orwin

Location
Redwood City, CA
Summary
The estimated net worth of John A. Orwin is at least $985,375 dollars as of 17 Sep 2025. John A. Orwin is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $648,423. John A. Orwin is the Director of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $307,905. John A. Orwin is the PRESIDENT & CEO, Director of Atreca, Inc. and owns shares of Atreca, Inc. stock worth about $29,047.
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when John A. Orwin files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of John A. Orwin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TVTX Travere Therapeutics, Inc. Director $648,423 15 May 2025
ANAB ANAPTYSBIO, INC Director $307,905 15 Sep 2025
BCEL Atreca, Inc. PRESIDENT & CEO, Director $29,047 11 Apr 2024
CRGX CARGO Therapeutics, Inc. Director 19 Aug 2025
SGEN Seagen Inc. Director 14 Dec 2023

Insider Transactions Reported by John A. Orwin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.